Meditech Overseas Private Limited
About Meditech Overseas Private Limited
Data last updated:
Meditech Overseas Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 29 April 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U51101UP2013PTC056576. Its GSTIN is 09AAICM5712E1ZJ (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Neelu Tandon and Anil Kumar Tandon.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Shop No U.G.F – 14 Mahabir Plaza 126/31/20 Beldari Lane Lalbagh, Lucknow, Uttar Pradesh, India – 226001.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.81 Cr, a growth of 59% compared to the previous year. For the same year it recorded a net profit of ₹17.12 Lakh (net margin 6.1%) and EBITDA of ₹28.37 Lakh (EBITDA margin 10.1%). Revenue has grown at a compounded annual rate (CAGR) of 44% over three years and 20% over five years.
As per MCA filings, the company has open charges of ₹1.79 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShop No U.G.F – 14 Mahabir Plaza 126/31/20 Beldari Lane Lalbagh, Lucknow, Uttar Pradesh, India – 226001
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Meditech Overseas Private Limited
The main business activity of Meditech Overseas is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Meditech Overseas Private Limited FY 2024 filings available
Meditech Overseas Private Limited reported revenue of ₹2.81 Cr (up 59% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Meditech Overseas Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 59% growth in the latest year. EBITDA rose 121% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Meditech Overseas Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹28.37 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹17.12 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Meditech Overseas Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 6.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Meditech Overseas are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Meditech Overseas Private Limited
Meditech Overseas Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Innovinc Healthcare Private Limited | ₹2.82 Cr (FY 2023) | •••• | •••• | -83.0% | •••• | Nagpur, Maharashtra, India |
| Ihl Medicare Private Limited | ₹2.82 Cr (FY 2025) | •••• | •••• | -80.0% | •••• | Mumbai, Maharashtra, India |
| Iatros Pharmaceutical Pvt Ltd | ₹2.82 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | Pune, Maharashtra, India |
| Amazone Pharmaceuticals Private Limited | ₹2.82 Cr (FY 2025) | •••• | •••• | 33.0% | •••• | Delhi, India |
| Renomed Lifesciences Private Limited | ₹2.81 Cr (FY 2024) | •••• | •••• | 193.0% | •••• | Guwahati, Assam, India |
| Meditech Overseas Private Limited this company | ₹2.81 Cr (FY 2024) | •••• | •••• | 59.0% | •••• | Lucknow, Uttar Pradesh, India |
| Axiom Pharma Private Limited | ₹2.81 Cr (FY 2025) | •••• | •••• | 86.0% | •••• | Jaipur, Rajasthan, India |
| Wel-Come Remedies Private Limited | ₹2.81 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Solan, Himachal Pradesh, India |
| Zyrath Health Care Private Limited | ₹2.81 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | Agra, Uttar Pradesh, India |
| M Biotech Private Limited | ₹2.81 Cr (FY 2024) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Dawa Deal Private Limited | ₹2.8 Cr (FY 2025) | •••• | •••• | 74.0% | •••• | Jaipur, Rajasthan, India |
Peers are the five companies nearest above and the five nearest below Meditech Overseas by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Meditech Overseas Private Limited
Meditech Overseas Private Limited is audited by K RAGHAV & ASSOCIATES for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| K RAGHAV & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Meditech Overseas Private Limited
Meditech Overseas has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neelu Tandon | Director | 01 May 2015 | 11 Years 5 Months | Current |
| Anil Kumar Tandon | Director | 29 Apr 2013 | 13 Years 5 Months | Current |
| Ankit Tandon | Director | 24 Sep 2016 | 10 Years 0 Months | Current |
Ownership and Shareholding of Meditech Overseas Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Meditech Overseas Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jun 2025 | Others | ₹20 Lakh | Open |
| 19 May 2022 | Hdfc Bank Limited | ₹9 Lakh | Open |
| 09 Nov 2021 | Hdfc Bank Limited | ₹1.5 Cr | Open |
Total charge records: 3 View all charges
Legal Cases of Meditech Overseas Private Limited
Meditech Overseas Private Limited has 2 court cases on record: 2 filed by Meditech Overseas. All cases are disposed. Status as checked on 30 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 0 |
Cases on record (1 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Lucknow, Uttar Pradesh | Cheque dishonour complaint | Filed by the company against an individual | Disposed |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Meditech Overseas Private Limited
Employment history and EPFO contributions of people linked to Meditech Overseas.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Meditech Overseas Private Limited
Meditech Overseas Private Limited has 4 board changes on record since 2013: 3 appointments and 1 cessation. The latest: Ankit Tandon was appointed as Director on 24 Sep 2016.
Credit Ratings, Litigation & Regulatory Alerts for Meditech Overseas Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Meditech Overseas Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Meditech Overseas Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Meditech Overseas Private Limited
Meditech Overseas has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAICM5712E1ZJ | Uttar Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Meditech Overseas Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Meditech Overseas Private Limited
Meditech Overseas is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 29 April 2013 (13+ years old) and is registered under CIN U51101UP2013PTC056576.
Meditech Overseas reported revenue of ₹2.81 Cr for FY 2024 (up 59% YoY).
Meditech Overseas has 3 current directors:
- Neelu Tandon - Director
- Anil Kumar Tandon - Director
- Ankit Tandon - Director
Meditech Overseas reported a net profit of ₹17.12 Lakh (net margin 6.1%) and EBITDA of ₹28.37 Lakh (EBITDA margin 10.1%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Meditech Overseas is 44% over three years and 20% over five years. In the latest year (FY 2024) revenue rose 59%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Meditech Overseas is 09AAICM5712E1ZJ, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Meditech Overseas is U51101UP2013PTC056576. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Meditech Overseas has 2 court cases on record: 2 filed by the company.
Meditech Overseas was incorporated on 29 April 2013, making it 13+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Meditech Overseas by revenue are Innovinc Healthcare Private Limited, Ihl Medicare Private Limited, Iatros Pharmaceutical Pvt Ltd, Amazone Pharmaceuticals Private Limited, Renomed Lifesciences Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Ankit Tandon was appointed as Director on 24 Sep 2016. Ankit Tandon ceased to be Director on 15 May 2015. Neelu Tandon was appointed as Director on 01 May 2015. Meditech Overseas has 4 board changes on record in total.